Dr. Jamie A Cooper, Ph.D.
Claim this profileUniversity of Georgia
Studies Dyslipidemia
Studies Obesity
2 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Jamie A Cooper, Ph.D. is currently running
Cottonseed Oil
for Dyslipidemia
Adding cottonseed oil to the diet has been shown to improve cholesterol profiles and other markers of chronic disease risk in both healthy and at-risk adults. However, CSO has only been tested in the context of high-fat diets. The goal of this clinical trial is to learn about the health effects of lower amounts of cottonseed oil (CSO) added to the diet in adults at increased risk for cardiovascular disease. The main questions it aims to answer are: * How do different amounts of CSO in the diet affect fasting cholesterol profiles and markers of liver function? * How do different amounts of CSO in the diet affect fasting and post-meal markers of lipid metabolism (i.e. triglycerides) and glycemic control (i.e. blood sugar and insulin)? * How do different amounts of CSO in the diet affect fasting and post-meal markers of chronic disease risk factors such as oxidative stress, inflammation, coagulation potential, and appetite control? Participants will be asked to: * Consume provided breakfast shakes and snacks daily for 28-days. * Attend three weekly short visits for fasting blood draws, body measurements, and collect the next week of study materials. * Attend two longer (5.5 h) testing visits which include eating a standardized breakfast meal and having blood drawn periodically before and after breakfast. Researchers will compare CSO LOW, CSO MID, CSO HIGH, and Control groups (receiving a mixture of oils) to see if lower doses of CSO in the diet impart the same health benefits as previously shown with high doses of CSO.
Recruiting1 award N/A3 criteria
Pecan Consumption
for Cardiometabolic Health
The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids than any other tree nut. They also are a rich source of polyunsaturated fatty acids (PUFAs), fiber, vitamin A, vitamin E, folic acid, calcium, magnesium, phosphorus, potassium, and zinc. These bioactive components in pecans are likely the reason for the previously documented improvements in cardiometabolic health. The specific aims of this study are to: * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on fasting and postprandial blood lipids. * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on plasma markers associated with overall health. * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on subjective and physiologic postprandial measures of hunger and satiety. Participants will be asked to: * Consume pecans daily for 28 days or maintain their current habitual diet. * Attend three short weekly visits for fasting blood craws, body measurements, and collect their next week's supply of study materials. * Attend two longer (5 h) testing visits which include consuming a standard breakfast meal and having their blood drawn periodically before and after breakfast. Researchers will compare pecan LOW, pecan MID, pecan HIGH, and the Control group to examine the physiologic effects of incorporating various dosages of pecans into one's diet.
Recruiting1 award N/A3 criteria
More about Jamie A Cooper, Ph.D.
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jamie A Cooper, Ph.D. has experience with
- CONTROL
- CSO HIGH
- CSO LOW
- CSO MID
- Pecan HIGH
- Pecan LOW
Breakdown of trials Jamie A Cooper, Ph.D. has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jamie A Cooper, Ph.D. specialize in?
Jamie A Cooper, Ph.D. focuses on Dyslipidemia and Obesity. In particular, much of their work with Dyslipidemia has involved treating patients, or patients who are undergoing treatment.
Is Jamie A Cooper, Ph.D. currently recruiting for clinical trials?
Yes, Jamie A Cooper, Ph.D. is currently recruiting for 2 clinical trials in Athens Georgia. If you're interested in participating, you should apply.
Are there any treatments that Jamie A Cooper, Ph.D. has studied deeply?
Yes, Jamie A Cooper, Ph.D. has studied treatments such as CONTROL, CSO HIGH, CSO LOW.
What is the best way to schedule an appointment with Jamie A Cooper, Ph.D.?
Apply for one of the trials that Jamie A Cooper, Ph.D. is conducting.
What is the office address of Jamie A Cooper, Ph.D.?
The office of Jamie A Cooper, Ph.D. is located at: University of Georgia, Athens, Georgia 30602 United States. This is the address for their practice at the University of Georgia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.